FDA Orange Book

Generic for Tykerb

Tykerb contains lapatinib ditosylate. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

Yes. The generic name for Tykerb is lapatinib ditosylate. 2 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.

Run it in Rivvi

Map Tykerb and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Tykerb products in the Orange Book

Tykerb products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
tablet, oralEQ 250MG BASEMarketed (Rx)AB2AB

NDA 022059, held by NOVARTIS PHARMACEUTICALS CORP. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Approved generic lapatinib ditosylate

Approved generic versions of Tykerb
CompanyANDATE codeApprovedStrengths
NATCO PHARMA LTD203007AB (A-rated, therapeutically equivalent)September 29, 2020EQ 250MG BASE
TEVA PHARMACEUTICALS USA INC217968AB (A-rated, therapeutically equivalent)August 16, 2024EQ 250MG BASE

Tykerb patents

Patents listed for Tykerb
PatentExpiresCoversUse codeNDA
8821927September 18, 2029Drug substance, Drug productNone022059

Tykerb NDC codes

Questions

Is there a generic for Tykerb?

Yes. The generic name for Tykerb is lapatinib ditosylate. 2 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.

What is the generic name for Tykerb?

The active ingredient in Tykerb is lapatinib ditosylate, per the FDA Orange Book.

When does the Tykerb patent expire?

The last patent listed for Tykerb in the Orange Book expires September 18, 2029. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Tykerb and Lapatinib Ditosylate

Try it on your own data today.

Free to start. Most teams are using it the same day.